Genetic study of Hirschsprung's disease
Genetic study of Hirschsprung's disease
批准号:
09671829
负责人:
KUSAFUKA Takeshi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
(1)分析散发性巨结肠病患者中RET、EDNRB、ET-3、SOX10基因是否存在突变。(2)定量比较获得的巨结肠病患者神经节和神经节肠段RET和EDNRB基因的表达。(3)在本研究中,大约10%的患者确认了RET或EDNRB基因的致病突变,并被认为与先天性巨结肠病的病因有关。另一方面,ET-3和SOX10基因未检测到突变,这些基因突变不太可能在疾病的发展中起作用。(4) RET基因突变与长片段型相关,EDNRB基因突变与短片段型相关。(5)在一些未检测到基因突变的病例中,神经节节段的RET基因表达明显低于正常神经节节段。因此,在这些病例中,胚胎发生期间RET的消除表达可能与Hirsehsprung病的发展有关。(6)在检查病例的神经节段观察到NOS基因的表达降低,似乎解释了Hirschsprung病的主要病理生理;神经节肠过度收缩
英文摘要
(1) Possible existence of mutations of the RET, EDNRB, ET-3, and SOX10 genes were analyzed in sporadic patients with Hirschsprung's disease.(2) Expression of the RET and EDNRB genes were quantified and compared in both ganglionic and aganglionic bowel segments obtained Hirschsprung's disease patients.(3) Disease causative mutations of the RET or EDNRB genes were confirmed approximately in 10% of the patients in the current study, and considered to be associated with the etiology of Hirschsprung's disease. On the other hand, no mutations were detected in the ET-3 and SOX10 genes, and it is unlikely that these gene mutations have a role in the development of the disease.(4) Mutations of the RET gene seemed to be associated with long segment type, while these of the EDNRB seemed to be associated with short segment type.(5) In several cases in whom no gene mutations were detected, RET gene expression in the aganglionic segment were apparently lower than that in the normal ganglionic segment. Therefore, it is likely that abolish expression of RET during embryogenesis may be associated with the development of Hirsehsprung's disease in these cases.(6) Decreased expression of NOS gene observed in the aganglionic segments of examined cases seemed to explain the principal pathophysiology of Hirschsprung's disease ; excessive contraction of the aganglionic bowels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kusafuka T. Puri P: "Genetic aspects of Hirschsprung's Disease"Semi Pediat-r Surg. 7. 145-155 (1998)
Kusafuka T. Puri P:“先天性巨结肠的遗传方面”Semi Pediat-r Surg。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kusafuka T: "Genetic aspects of Hirschsprungs disoase"Semi Pediatr Surg. 7. 148-155 (1998)
Kusafuka T:“先天性巨结肠疾病的遗传方面”半儿科外科。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kusafuka T.: "Genetic aspects of Hirschsprung's disease" Semi.Pediatr Surg. 7・3. 148-155 (1998)
Kusafuka T.:“先天性巨结肠症的遗传方面”Semi.Pediatr Surg. 7・3(1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Genetic alterations in nephroblastomas and anti-proliferating effects induced by silencing of the tumor-related genes.
-
批准号:18591954
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.49万
-
财政年份:2006
-
负责人:KUSAFUKA Takeshi
-
依托单位:
In vitro RNA interference against beta-catenin inhibiting the proliferation of pediatric hepatic tumors
-
批准号:16591785
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2004
-
负责人:KUSAFUKA Takeshi
-
依托单位:
β-catenin and its related gene mutations in childhood solid tumors
-
批准号:14571704
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2002
-
负责人:KUSAFUKA Takeshi
-
依托单位:
β-catenin abnormalities in pediatric malignant solid tumors
-
批准号:12671738
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2000
-
负责人:KUSAFUKA Takeshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于机器学习与分子模拟的新型靶向RET激酶抑制剂筛选与抗肿瘤活性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:左柯
-
依托单位:
基于RET理论模型下的曼陀罗彩绘疗法在老年HIV/AIDS患者中的心理干预研究
-
批准号:2025JJ80476
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:余一知
-
依托单位:
克服突变耐药的新型RET抑制剂的设计、合成及抗肿瘤活性研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:彭丽洁
-
依托单位:
甘草酚通过肠胶质细胞GDNF/RET途径促进ZO-1与肠上皮细胞膜融合保护肠粘膜机械屏障的作用与机制研究
-
批准号:82304147
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:路上云
-
依托单位:
RET基因M918T突变通过JAK/STAT3信号通路轴调控腱糖蛋白C表达促进甲状腺髓样癌细胞干性的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:史潇
-
依托单位:
RET-M918T突变通过调控Tenascin C-EGFR复合体形成促进甲状腺髓样癌干性和侵袭转移的机制研究
-
批准号:82373008
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:史潇
-
依托单位:
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
-
批准号:82370790
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶蕾
-
依托单位:
SPP1+巨噬细胞促肺癌细胞MET活化介导RET抑制剂耐药的机制研究
-
批准号:82303643
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:鲁畅
-
依托单位:
近视视觉信息通过N-retinylidene-PE(N-ret-PE)通路促进视杆光感受器视紫红质再生参与近视
-
批准号:82271121
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2022
-
负责人:支知娜
-
依托单位:
GDNF-RET介导电针调节神经-结肠上皮对话缓解PI-IBS模型小鼠内脏高敏感的机制研究
-
批准号:82274630
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:孙建华
-
依托单位: